Gul CB - Search Results

1

Evaluation of serum Spondin 2 levels in the different stages of Type 2 diabetic nephropathy.

Kahvecioglu S, Guclu M, Ustundag Y, Gul CB, Dogan I, Dagel T, Esen B, Akturk Esen S, Celik H, Esen I. Kahvecioglu S, et al. Among authors: gul cb. Nephrology (Carlton). 2015 Oct;20(10):721-726. doi: 10.1111/nep.12507. Nephrology (Carlton). 2015. PMID: 25973958

2

Comparative effects of pioglitazone and rosiglitazone on plasma levels of soluble receptor for advanced glycation end products in type 2 diabetes mellitus patients.

Oz Gul O, Tuncel E, Yilmaz Y, Ulukaya E, Gul CB, Kiyici S, Oral AY, Guclu M, Ersoy C, Imamoglu S. Oz Gul O, et al. Among authors: gul cb. Metabolism. 2010 Jan;59(1):64-9. doi: 10.1016/j.metabol.2009.07.006. Epub 2009 Aug 26. Metabolism. 2010. PMID: 19709689 Clinical Trial.

3

Arterial dysfunction in early autosomal dominant polycystic kidney disease independent of fibroblast growth factor 23.

Yildiz A, Gul CB, Ersoy A, Asiltas B, Ermurat S, Dogan S, Karaagac K, Sag S, Oruc A, Aktas N, Ocakoglu G, Dogan I, Gullulu S, Gullulu M. Yildiz A, et al. Among authors: gul cb. Iran J Kidney Dis. 2014 Nov;8(6):443-9. Iran J Kidney Dis. 2014. PMID: 25362218 Free article.

4

Correlation between arterial stiffness and inflammatory markers in autosomal dominant polycystic kidney disease patients with preserved renal function.

Gul CB, Yildiz A, Ersoy A, Kahvecioglu S, Asiltas B, Yildirim F, Ermurat S, Sag S, Oruc A, Gullulu S, Gullulu M. Gul CB, et al. Int Urol Nephrol. 2015 Jul;47(7):1187-94. doi: 10.1007/s11255-015-1022-0. Epub 2015 Jun 6. Int Urol Nephrol. 2015. PMID: 26047596

5

Restless-legs syndrome and insomnia in hemodialysis patients.

Yildiz D, Kahvecioğlu S, Buyukkoyuncu N, Kilic AK, Yildiz A, Gul CB, Seferoglu M, Tufan F. Yildiz D, et al. Among authors: gul cb. Ren Fail. 2016;38(2):194-7. doi: 10.3109/0886022X.2015.1111118. Epub 2015 Nov 10. Ren Fail. 2016. PMID: 26554439 Free article.

6

Fluvastatin Decreases Oxidative Stress in Kidney Transplant Patients.

Yildiz A, Gul CB, Ocak N, Ersoy A, Sag S, Oruc A, Ayar Y, Dagel T, Dirican M, Gullulu M. Yildiz A, et al. Among authors: gul cb. Transplant Proc. 2015 Dec;47(10):2870-4. doi: 10.1016/j.transproceed.2015.10.027. Transplant Proc. 2015. PMID: 26707305

7

Acute Urinary Retention and Acute Kidney Injury After Duloxetine Treatment: A Rare Case Report.

Aktürk Esen S, Gül CB, Kahvecioğlu S, Aktaş N, Esen İ. Aktürk Esen S, et al. Among authors: gul cb. J Clin Psychopharmacol. 2019 May/Jun;39(3):279-281. doi: 10.1097/JCP.0000000000001020. J Clin Psychopharmacol. 2019. PMID: 30908353 No abstract available.

8

The Comparison Spondin 2 Levels in Primary Glomerular Diseases.

Kahvecioglu S, Ersoy A, Üstundag Y, Ayar Y, Gül CB, Yildiz A, Esen SA, Dogan I, Oruc A. Kahvecioglu S, et al. Among authors: gul cb. Saudi J Kidney Dis Transpl. 2020 Sep-Oct;31(5):1014-1024. doi: 10.4103/1319-2442.301166. Saudi J Kidney Dis Transpl. 2020. PMID: 33229764

9

Comparison of all renal replacement therapy modalities in terms of COVID-19 infection rate & mortality in the COVID-19 pandemic and importance of home therapies.

Kahvecioglu S, Bilen N, Celik H, Gul CB, Usta M, Aktaş N, Bilen Y. Kahvecioglu S, et al. Among authors: gul cb. Ther Apher Dial. 2023 Jun;27(3):402-411. doi: 10.1111/1744-9987.13930. Epub 2022 Oct 6. Ther Apher Dial. 2023. PMID: 36125437 Free PMC article.

10

Influence of erythropoietin therapy on serum prohepcidin levels in dialysis patients.

Arabul M, Gullulu M, Yilmaz Y, Eren MA, Baran B, Gul CB, Kocamaz G, Dilek K. Arabul M, et al. Among authors: gul cb. Med Sci Monit. 2009 Nov;15(11):CR583-7. Med Sci Monit. 2009. PMID: 19865058 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

30 results

Search Page

Filters